Dr. Anna ME Bruynzeel

Amsterdam UMC (formerly VUmc)

Since 2012 Anna ME Bruynzeel is Radiation Oncologist at the VU University Medical Center Amsterdam, the Netherlands. Her areas of interest are Neuro-Oncology, Gastrointestinal tract Oncology, Stereotactic Ablative Radiotherapy and MR-guided Radiotherapy. The latter has recently been introduced in clinical practice using the MRIdian system. Anna belongs to the core team developing protocols and performing MR- guided adaptive treatment including patients with locally advanced pancreatic tumors, prostate cancer and kidney cancer.

dont miss

MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

MR-guided radiation therapy (MRgRT) is a novel and rapidly expanding treatment approach which has been clinically implemented at VUmc Amsterdam since early 2016. In addition to MR-based setup, it offers the potential for real-time target tracking during treatment, marker-less gated delivery, and if indicated, plan re-optimization to generate an optimal ´plan of the day’ for each fraction. MRgRT workflow, benefits, limitations, indications as well as early clinical results will be presented.

EVEN MORE SEMINARS

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view